These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6443774)

  • 1. Treatment of urinary tract infections due to Pseudomonas aeruginosa with cefsulodin.
    Elder HA; Roy I
    Rev Infect Dis; 1984; 6 Suppl 3():S734-43. PubMed ID: 6443774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns.
    Heimbach DM
    Rev Infect Dis; 1984; 6 Suppl 3():S744-50. PubMed ID: 6443775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
    Montgomerie JZ; Morrow JW; Canawati HN; Gilmore DS; Graham IE; Ibraham MZ
    Urology; 1986 Nov; 28(5):446-50. PubMed ID: 3787915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia.
    Nichols L; Gudmundsson S; Maki DG
    Rev Infect Dis; 1984; 6 Suppl 3():S711-20. PubMed ID: 6443772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
    Caplan DB; Buchanan CN
    Rev Infect Dis; 1984; 6 Suppl 3():S705-10. PubMed ID: 6443771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin-resistant Pseudomonas aeruginosa: Mayo Clinic Experience, 1970-1976.
    Keys TF; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):797-801. PubMed ID: 413012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa.
    Baltch AL; Bassey C; Hammer MC; Smith RP; Conroy JV; Michelsen PB
    J Antimicrob Chemother; 1991 Jun; 27(6):801-8. PubMed ID: 1938686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
    Chandrasekar PH; Crane LR; Bailey EJ
    J Antimicrob Chemother; 1987 Mar; 19(3):321-9. PubMed ID: 3106305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of cefsulodin and other agents against Pseudomonas aeruginosa.
    Neu HC; Scully BE
    Rev Infect Dis; 1984; 6 Suppl 3():S667-77. PubMed ID: 6443768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefsulodin treatment for serious Pseudomonas aeruginosa infections.
    Routman A; Van Manen W; Haddad R; Pollock B; Holmes B; Mogabgab WJ
    J Int Med Res; 1986; 14(5):242-53. PubMed ID: 3770290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefsulodin therapy for osteomyelitis due to Pseudomonas aeruginosa.
    Pottage JC; Karakusis PH; Trenholme GM
    Rev Infect Dis; 1984; 6 Suppl 3():S728-33. PubMed ID: 6443773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of cefmenoxime and cefsulodin in the treatment of complicated urinary tract infections caused by Pseudomonas aeruginosa.
    Doi T; Nishiura T; Deguchi K; Kondo M
    Chemotherapy; 1986; 32(3):299-304. PubMed ID: 3458567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.
    van der Meer JW; Matze-van der Lans A; Mattie H
    Neth J Med; 1989 Jun; 34(5-6):233-42. PubMed ID: 2671757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
    Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin.
    Møller NE; Koch C; Vesterhauge S; Jensen K
    Scand J Infect Dis; 1982; 14(3):207-11. PubMed ID: 6815787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sisomicin: an aminoglycoside antibiotic that is highly effective against Pseudomonas.
    Sanders WE; Sanders CC
    J Int Med Res; 1981; 9(3):168-76. PubMed ID: 6786934
    [No Abstract]   [Full Text] [Related]  

  • 19. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to cefsulodin and gentamicin in Pseudomonas aeruginosa strains in five areas of Japan between 1980 and 1983.
    Furusawa T; Uete T; Kawada T; Kuwahara M; Okuma A
    J Antimicrob Chemother; 1986 Jun; 17(6):755-62. PubMed ID: 3090008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.